483 Hercon Pharmaceuticals Sep 2000

483 Hercon Pharmaceuticals Sep 2000

David Hafner FDA$119.00 - Available Now

FDA investigators audited the Hercon Pharmaceuticals - Emigsville, PA, United States facility and issued inspectional observations (via FDA 483) on 01 Sep 2000.

Product details

  • Category: Human Drugs
  • Inspection end: 01 Sep 2000
  • Location: Emigsville, United States
  • FEI: 2522638
Add To Cart